Cargando…

Network pharmacology and in vivo experiment-based strategy to investigate mechanisms of JingFangFuZiLiZhong formula for ulcerative colitis

BACKGROUND: Ulcerative colitis (UC), a chronic inflammatory disease, often cause carcinogenesis, disability, and intestinal perforation. The JingFangFuZiLiZhong formula (JFFZLZ) shows a good effect against UC in the clinic. Hence, we aim to investigate the mechanisms between JFFZLZ and UC via networ...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mengyuan, Li, Jianan, Yin, Yuzhang, Liu, Liying, Wang, Yifei, Qu, Ying, Hong, Yanqiu, Ji, Shuangshuang, Zhang, Tao, Wang, Nan, Liu, Jinlong, Cao, Xu, Zao, Xiaobin, Zhang, Shuxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673803/
https://www.ncbi.nlm.nih.gov/pubmed/36382627
http://dx.doi.org/10.1080/07853890.2022.2095665
_version_ 1784833025581776896
author Wang, Mengyuan
Li, Jianan
Yin, Yuzhang
Liu, Liying
Wang, Yifei
Qu, Ying
Hong, Yanqiu
Ji, Shuangshuang
Zhang, Tao
Wang, Nan
Liu, Jinlong
Cao, Xu
Zao, Xiaobin
Zhang, Shuxin
author_facet Wang, Mengyuan
Li, Jianan
Yin, Yuzhang
Liu, Liying
Wang, Yifei
Qu, Ying
Hong, Yanqiu
Ji, Shuangshuang
Zhang, Tao
Wang, Nan
Liu, Jinlong
Cao, Xu
Zao, Xiaobin
Zhang, Shuxin
author_sort Wang, Mengyuan
collection PubMed
description BACKGROUND: Ulcerative colitis (UC), a chronic inflammatory disease, often cause carcinogenesis, disability, and intestinal perforation. The JingFangFuZiLiZhong formula (JFFZLZ) shows a good effect against UC in the clinic. Hence, we aim to investigate the mechanisms between JFFZLZ and UC via network pharmacology data mining and in vivo experiments. METHODS: We obtained active constituents and related targets from public databases. The overlapped genes between JFFZLZ and UC targets were further analysed by enrichment analysis. The active constituents and hub targets were used to construct molecule docking analysis. We finally screened out nine hub targets and their expressions were verified in the Gene Expression Omnibus database and UC rats’ colon tissues after JFFZLZ treatment. RESULTS: The results implied that JFFZLZ mainly regulated signal transduction, metabolites production, and inflammation pathways. The expression of STAT3, CXCL8, IL6, CXCL12, TNF, TP53, and PTPN11 were both upregulated in colon tissues of UC patients and UC rats. While RELA, EGFR, and TP53 were downregulated in UC patients, but upregulated in UC rats. Furthermore, JFFZLZ could repair UC rats’ colon mucosal damage and promote the healing of ulcers via regulating the hub targets. CONCLUSION: These results elucidated that the anti-UC effect of JFFZLZ was closely related to the inhibition of inflammatory response, inhibition of oxidative stress, and repairing colon mucosal damage through different signal pathways. The findings could contribute to a better understanding of the regulation mechanisms in JFFZLZ against UC. KEY MESSAGES: JFFZLZ could reduce the inflammatory infiltration and repair UC rats’ colon mucosal damage. Through the network pharmacology-based strategy and public database mining, we obtained the hub targets and key pathways between JFFZLF and UC. The mechanism of JFFZLZ against UC was inhibition of inflammatory response and oxidative stress by regulating the expression of the hub targets.
format Online
Article
Text
id pubmed-9673803
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-96738032022-11-19 Network pharmacology and in vivo experiment-based strategy to investigate mechanisms of JingFangFuZiLiZhong formula for ulcerative colitis Wang, Mengyuan Li, Jianan Yin, Yuzhang Liu, Liying Wang, Yifei Qu, Ying Hong, Yanqiu Ji, Shuangshuang Zhang, Tao Wang, Nan Liu, Jinlong Cao, Xu Zao, Xiaobin Zhang, Shuxin Ann Med Pharmacology BACKGROUND: Ulcerative colitis (UC), a chronic inflammatory disease, often cause carcinogenesis, disability, and intestinal perforation. The JingFangFuZiLiZhong formula (JFFZLZ) shows a good effect against UC in the clinic. Hence, we aim to investigate the mechanisms between JFFZLZ and UC via network pharmacology data mining and in vivo experiments. METHODS: We obtained active constituents and related targets from public databases. The overlapped genes between JFFZLZ and UC targets were further analysed by enrichment analysis. The active constituents and hub targets were used to construct molecule docking analysis. We finally screened out nine hub targets and their expressions were verified in the Gene Expression Omnibus database and UC rats’ colon tissues after JFFZLZ treatment. RESULTS: The results implied that JFFZLZ mainly regulated signal transduction, metabolites production, and inflammation pathways. The expression of STAT3, CXCL8, IL6, CXCL12, TNF, TP53, and PTPN11 were both upregulated in colon tissues of UC patients and UC rats. While RELA, EGFR, and TP53 were downregulated in UC patients, but upregulated in UC rats. Furthermore, JFFZLZ could repair UC rats’ colon mucosal damage and promote the healing of ulcers via regulating the hub targets. CONCLUSION: These results elucidated that the anti-UC effect of JFFZLZ was closely related to the inhibition of inflammatory response, inhibition of oxidative stress, and repairing colon mucosal damage through different signal pathways. The findings could contribute to a better understanding of the regulation mechanisms in JFFZLZ against UC. KEY MESSAGES: JFFZLZ could reduce the inflammatory infiltration and repair UC rats’ colon mucosal damage. Through the network pharmacology-based strategy and public database mining, we obtained the hub targets and key pathways between JFFZLF and UC. The mechanism of JFFZLZ against UC was inhibition of inflammatory response and oxidative stress by regulating the expression of the hub targets. Taylor & Francis 2022-11-16 /pmc/articles/PMC9673803/ /pubmed/36382627 http://dx.doi.org/10.1080/07853890.2022.2095665 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pharmacology
Wang, Mengyuan
Li, Jianan
Yin, Yuzhang
Liu, Liying
Wang, Yifei
Qu, Ying
Hong, Yanqiu
Ji, Shuangshuang
Zhang, Tao
Wang, Nan
Liu, Jinlong
Cao, Xu
Zao, Xiaobin
Zhang, Shuxin
Network pharmacology and in vivo experiment-based strategy to investigate mechanisms of JingFangFuZiLiZhong formula for ulcerative colitis
title Network pharmacology and in vivo experiment-based strategy to investigate mechanisms of JingFangFuZiLiZhong formula for ulcerative colitis
title_full Network pharmacology and in vivo experiment-based strategy to investigate mechanisms of JingFangFuZiLiZhong formula for ulcerative colitis
title_fullStr Network pharmacology and in vivo experiment-based strategy to investigate mechanisms of JingFangFuZiLiZhong formula for ulcerative colitis
title_full_unstemmed Network pharmacology and in vivo experiment-based strategy to investigate mechanisms of JingFangFuZiLiZhong formula for ulcerative colitis
title_short Network pharmacology and in vivo experiment-based strategy to investigate mechanisms of JingFangFuZiLiZhong formula for ulcerative colitis
title_sort network pharmacology and in vivo experiment-based strategy to investigate mechanisms of jingfangfuzilizhong formula for ulcerative colitis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673803/
https://www.ncbi.nlm.nih.gov/pubmed/36382627
http://dx.doi.org/10.1080/07853890.2022.2095665
work_keys_str_mv AT wangmengyuan networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT lijianan networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT yinyuzhang networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT liuliying networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT wangyifei networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT quying networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT hongyanqiu networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT jishuangshuang networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT zhangtao networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT wangnan networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT liujinlong networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT caoxu networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT zaoxiaobin networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis
AT zhangshuxin networkpharmacologyandinvivoexperimentbasedstrategytoinvestigatemechanismsofjingfangfuzilizhongformulaforulcerativecolitis